5 assets in Muscular Dystrophy

Therapeutic assets addressing Muscular Dystrophy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Aoc 1044 Muscular Dystrophy	Avidity Biosciences, Inc.	P3	B (60)
Deramiocel Muscular Dystrophy	Capricor Inc.	P3	B (60)
Tadalafil Muscular Dystrophy	University of Florida	P2	B (60)
Zeleciment Rostudirsen Muscular Dystrophy	Dyne Therapeutics	P3	B (60)
Sat-3247 Muscular Dystrophy	Satellos Bioscience, Inc.	P2	CCC (53)